Skip to main content
Erschienen in: Discover Oncology 4/2016

19.04.2016 | Original Paper

Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid

Erschienen in: Discover Oncology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

The local endocrine environment of the breast may have stronger relations to breast cancer risk than systemic hormones. Nipple aspiration fluid (NAF) provides a window into this milieu. We hypothesized that the correlations between proteins and steroid hormones in NAF are stronger, and specific relationships may reveal links to breast cancer risk. NAF and blood samples were obtained simultaneously from 54 healthy women and from the contralateral unaffected breast of 60 breast cancer patients. The abundance of five proteins, superoxide dismutase (SOD1), C-reactive protein (CRP), chitinase-3-like protein 1 (YKL40), cathepsin D (CatD), and basic fibroblast growth factor (bFGF) in NAF was measured using ELISA. The NAF and serum concentrations of estradiol, estrone, progesterone, androstenedione, testosterone, and dehydroepiandrostrerone (DHEA) were measured using ELISA or RIA. The correlations between proteins and hormones revealed that NAF proteins correlated with each other: SOD1 with CRP (R = 0.276, P = 0.033) and CatD (R = 0.340, P = 0.0036), and bFGF with CRP (R = 0.343, P = 0.0021). NAF proteins displayed significant correlations with NAF steroids, but not with serum steroids: SOD1 with DHEA (R = 0.333, P = 0.019), YKL40 with testosterone (R = 0.389, P = 0.0012), and bFGF negatively correlated with testosterone (R = −0.339, P = 0.015). The regulation of YKL40 and bFGF by testosterone was confirmed in breast cancer cell lines. In summary, NAF proteins were more strongly related to local hormone levels than to systematic hormone levels. Some proteins were specifically correlated with different NAF steroids, suggesting that these steroids may contribute to breast cancer risk through different mechanisms.
Literatur
1.
Zurück zum Zitat de Waard F, Thijssen JH (2005) Hormonal aspects in the causation of human breast cancer: epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy. J Steroid Biochem Mol Biol 97:451–458CrossRefPubMed de Waard F, Thijssen JH (2005) Hormonal aspects in the causation of human breast cancer: epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy. J Steroid Biochem Mol Biol 97:451–458CrossRefPubMed
2.
Zurück zum Zitat Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6:213–218CrossRefPubMedPubMedCentral Hankinson SE, Colditz GA, Willett WC (2004) Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6:213–218CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE Jr, Chang L, Miller R, Franz C, Falk RT, Kahle L (1997) Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 6:177–181PubMed Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE Jr, Chang L, Miller R, Franz C, Falk RT, Kahle L (1997) Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 6:177–181PubMed
4.
Zurück zum Zitat Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90:1292–1299CrossRefPubMed Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90:1292–1299CrossRefPubMed
5.
Zurück zum Zitat Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A, Thiebaut A, Tjonneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97:755–765CrossRefPubMed Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quiros JR, Roddam A, Thiebaut A, Tjonneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E (2005) Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 97:755–765CrossRefPubMed
6.
Zurück zum Zitat Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856–1865CrossRefPubMed Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96:1856–1865CrossRefPubMed
7.
Zurück zum Zitat Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P, Totis A, Fariselli G, Di Pietro S (1991) Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 51:2572–2576PubMed Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P, Totis A, Fariselli G, Di Pietro S (1991) Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 51:2572–2576PubMed
8.
Zurück zum Zitat Tworoger SS, Rosner BA, Willett WC, Hankinson SE (2011) The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 13:R99CrossRefPubMedPubMedCentral Tworoger SS, Rosner BA, Willett WC, Hankinson SE (2011) The combined influence of multiple sex and growth hormones on risk of postmenopausal breast cancer: a nested case-control study. Breast Cancer Res 13:R99CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Khan SA, Bhandare D, Chatterton RT Jr (2005) The local hormonal environment and related biomarkers in the normal breast. Endocr Relat Cancer 12:497–510CrossRefPubMed Khan SA, Bhandare D, Chatterton RT Jr (2005) The local hormonal environment and related biomarkers in the normal breast. Endocr Relat Cancer 12:497–510CrossRefPubMed
10.
Zurück zum Zitat Chatterton RT Jr, Geiger AS, Khan SA, Helenowski IB, Jovanovic BD, Gann PH (2004) Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol Biomarkers Prev 13:928–935PubMed Chatterton RT Jr, Geiger AS, Khan SA, Helenowski IB, Jovanovic BD, Gann PH (2004) Variation in estradiol, estradiol precursors, and estrogen-related products in nipple aspirate fluid from normal premenopausal women. Cancer Epidemiol Biomarkers Prev 13:928–935PubMed
11.
Zurück zum Zitat Chatterton RT, Heinz RE, Fought AJ, Ivancic D, Shappell C, Allu S, Gapstur S, Scholtens DM, Gann PH, Khan SA (2016) Nipple aspirate fluid hormone concentrations and breast cancer risk. Horm Cancer 7:127–136CrossRefPubMed Chatterton RT, Heinz RE, Fought AJ, Ivancic D, Shappell C, Allu S, Gapstur S, Scholtens DM, Gann PH, Khan SA (2016) Nipple aspirate fluid hormone concentrations and breast cancer risk. Horm Cancer 7:127–136CrossRefPubMed
12.
Zurück zum Zitat Alexander H, Stegner AL, Wagner-Mann C, Du Bois GC, Alexander S, Sauter ER (2004) Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res 10:7500–7510CrossRefPubMed Alexander H, Stegner AL, Wagner-Mann C, Du Bois GC, Alexander S, Sauter ER (2004) Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clin Cancer Res 10:7500–7510CrossRefPubMed
13.
Zurück zum Zitat He J, Gornbein J, Shen D, Lu M, Rovai LE, Shau H, Katz J, Whitelegge JP, Faull KF, Chang HR (2007) Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry. Int J Oncol 30:145–154PubMed He J, Gornbein J, Shen D, Lu M, Rovai LE, Shau H, Katz J, Whitelegge JP, Faull KF, Chang HR (2007) Detection of breast cancer biomarkers in nipple aspirate fluid by SELDI-TOF and their identification by combined liquid chromatography-tandem mass spectrometry. Int J Oncol 30:145–154PubMed
14.
Zurück zum Zitat Li J, Zhao J, Yu X, Lange J, Kuerer H, Krishnamurthy S, Schilling E, Khan SA, Sukumar S, Chan DW (2005) Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res 11:8312–8320CrossRefPubMed Li J, Zhao J, Yu X, Lange J, Kuerer H, Krishnamurthy S, Schilling E, Khan SA, Sukumar S, Chan DW (2005) Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid. Clin Cancer Res 11:8312–8320CrossRefPubMed
15.
Zurück zum Zitat Mannello F, Fabbri L, Ciandrini E, Tonti GA (2008) Increased levels of erythropoietin in nipple aspirate fluid and in ductal cells from breast cancer patients. Cell Oncol 30:51–61PubMedPubMedCentral Mannello F, Fabbri L, Ciandrini E, Tonti GA (2008) Increased levels of erythropoietin in nipple aspirate fluid and in ductal cells from breast cancer patients. Cell Oncol 30:51–61PubMedPubMedCentral
16.
Zurück zum Zitat Mannello F, Qin W, Zhu W, Fabbri L, Tonti GA, Sauter ER (2008) Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2. Breast Cancer Res Treat 111:209–218CrossRefPubMed Mannello F, Qin W, Zhu W, Fabbri L, Tonti GA, Sauter ER (2008) Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2. Breast Cancer Res Treat 111:209–218CrossRefPubMed
17.
Zurück zum Zitat Mannello F, Tonti GA, Medda V, Pederzoli A, Sauter ER (2008) Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer. Cancer Sci 99:2160–2169CrossRefPubMed Mannello F, Tonti GA, Medda V, Pederzoli A, Sauter ER (2008) Increased shedding of soluble fragments of P-cadherin in nipple aspirate fluids from women with breast cancer. Cancer Sci 99:2160–2169CrossRefPubMed
18.
Zurück zum Zitat Noble JL, Dua RS, Coulton GR, Isacke CM, Gui GP (2007) A comparative proteinomic analysis of nipple aspiration fluid from healthy women and women with breast cancer. Eur J Cancer 43:2315–2320CrossRefPubMed Noble JL, Dua RS, Coulton GR, Isacke CM, Gui GP (2007) A comparative proteinomic analysis of nipple aspiration fluid from healthy women and women with breast cancer. Eur J Cancer 43:2315–2320CrossRefPubMed
19.
Zurück zum Zitat Paweletz CP, Trock B, Pennanen M, Tsangaris T, Magnant C, Liotta LA, Petricoin EF 3rd (2001) Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers 17:301–307CrossRefPubMed Paweletz CP, Trock B, Pennanen M, Tsangaris T, Magnant C, Liotta LA, Petricoin EF 3rd (2001) Proteomic patterns of nipple aspirate fluids obtained by SELDI-TOF: potential for new biomarkers to aid in the diagnosis of breast cancer. Dis Markers 17:301–307CrossRefPubMed
20.
Zurück zum Zitat Pawlik TM, Fritsche H, Coombes KR, Xiao L, Krishnamurthy S, Hunt KK, Pusztai L, Chen JN, Clarke CH, Arun B, Hung MC, Kuerer HM (2005) Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat 89:149–157CrossRefPubMed Pawlik TM, Fritsche H, Coombes KR, Xiao L, Krishnamurthy S, Hunt KK, Pusztai L, Chen JN, Clarke CH, Arun B, Hung MC, Kuerer HM (2005) Significant differences in nipple aspirate fluid protein expression between healthy women and those with breast cancer demonstrated by time-of-flight mass spectrometry. Breast Cancer Res Treat 89:149–157CrossRefPubMed
21.
Zurück zum Zitat Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, Kuerer HM (2006) Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 6:68CrossRefPubMedPubMedCentral Pawlik TM, Hawke DH, Liu Y, Krishnamurthy S, Fritsche H, Hunt KK, Kuerer HM (2006) Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. BMC Cancer 6:68CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Qin W, Zhu W, Wagner-Mann C, Sauter ER (2003) Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease. Ann Surg Oncol 10:948–953CrossRefPubMed Qin W, Zhu W, Wagner-Mann C, Sauter ER (2003) Nipple aspirate fluid expression of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor predicts breast cancer diagnosis and advanced disease. Ann Surg Oncol 10:948–953CrossRefPubMed
23.
Zurück zum Zitat Sauter ER, Zhu W, Fan XJ, Wassell RP, Chervoneva I, Du Bois GC (2002) Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer. Br J Cancer 86:1440–1443CrossRefPubMedPubMedCentral Sauter ER, Zhu W, Fan XJ, Wassell RP, Chervoneva I, Du Bois GC (2002) Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer. Br J Cancer 86:1440–1443CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Varnum SM, Covington CC, Woodbury RL, Petritis K, Kangas LJ, Abdullah MS, Pounds JG, Smith RD, Zangar RC (2003) Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer. Breast Cancer Res Treat 80:87–97CrossRefPubMed Varnum SM, Covington CC, Woodbury RL, Petritis K, Kangas LJ, Abdullah MS, Pounds JG, Smith RD, Zangar RC (2003) Proteomic characterization of nipple aspirate fluid: identification of potential biomarkers of breast cancer. Breast Cancer Res Treat 80:87–97CrossRefPubMed
25.
Zurück zum Zitat Hsiung R, Zhu W, Klein G, Qin W, Rosenberg A, Park P, Rosato E, Sauter E (2002) High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer. Cancer J 8:303–310CrossRefPubMed Hsiung R, Zhu W, Klein G, Qin W, Rosenberg A, Park P, Rosato E, Sauter E (2002) High basic fibroblast growth factor levels in nipple aspirate fluid are correlated with breast cancer. Cancer J 8:303–310CrossRefPubMed
26.
Zurück zum Zitat Sartippour MR, Zhang L, Lu M, Wang HJ, Brooks MN (2005) Nipple fluid basic fibroblast growth factor in patients with breast cancer. Cancer Epidemiol Biomarkers Prev 14:2995–2998CrossRefPubMed Sartippour MR, Zhang L, Lu M, Wang HJ, Brooks MN (2005) Nipple fluid basic fibroblast growth factor in patients with breast cancer. Cancer Epidemiol Biomarkers Prev 14:2995–2998CrossRefPubMed
27.
Zurück zum Zitat Sauter ER, Wagner-Mann C, Ehya H, Klein-Szanto A (2007) Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings. Cancer Detect Prev 31:50–58CrossRefPubMedPubMedCentral Sauter ER, Wagner-Mann C, Ehya H, Klein-Szanto A (2007) Biologic markers of breast cancer in nipple aspirate fluid and nipple discharge are associated with clinical findings. Cancer Detect Prev 31:50–58CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Sanchez LM, Ferrando AA, Diez-Itza I, Vizoso F, Ruibal A, Lopez-Otin C (1993) Cathepsin D in breast secretions from women with breast cancer. Br J Cancer 67:1076–1081CrossRefPubMedPubMedCentral Sanchez LM, Ferrando AA, Diez-Itza I, Vizoso F, Ruibal A, Lopez-Otin C (1993) Cathepsin D in breast secretions from women with breast cancer. Br J Cancer 67:1076–1081CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Lithgow D, Nyamathi A, Elashoff D, Martinez-Maza O, Covington C (2006) C-reactive protein in nipple aspirate fluid: relation to women’s health factors. Nurs Res 55:418–425CrossRefPubMed Lithgow D, Nyamathi A, Elashoff D, Martinez-Maza O, Covington C (2006) C-reactive protein in nipple aspirate fluid: relation to women’s health factors. Nurs Res 55:418–425CrossRefPubMed
30.
Zurück zum Zitat Lithgow D, Nyamathi A, Elashoff D, Martinez-Maza O, Covington C (2007) C-reactive protein in nipple aspirate fluid associated with Gail model factors. Biol Res Nurs 9:108–116CrossRefPubMed Lithgow D, Nyamathi A, Elashoff D, Martinez-Maza O, Covington C (2007) C-reactive protein in nipple aspirate fluid associated with Gail model factors. Biol Res Nurs 9:108–116CrossRefPubMed
31.
Zurück zum Zitat Mannello F, Tonti GA, Simone P, Ligi D, Medda V (2010) Iron-binding proteins and C-reactive protein in nipple aspirate fluids: role of iron-driven inflammation in breast cancer microenvironment? Am J Transl Res 3:100–113PubMedPubMedCentral Mannello F, Tonti GA, Simone P, Ligi D, Medda V (2010) Iron-binding proteins and C-reactive protein in nipple aspirate fluids: role of iron-driven inflammation in breast cancer microenvironment? Am J Transl Res 3:100–113PubMedPubMedCentral
32.
Zurück zum Zitat Qin W, Zhu W, Schlatter L, Miick R, Loy TS, Atasoy U, Hewett JE, Sauter ER (2007) Increased expression of the inflammatory protein YKL-40 in precancers of the breast. Int J Cancer 121:1536–1542CrossRefPubMed Qin W, Zhu W, Schlatter L, Miick R, Loy TS, Atasoy U, Hewett JE, Sauter ER (2007) Increased expression of the inflammatory protein YKL-40 in precancers of the breast. Int J Cancer 121:1536–1542CrossRefPubMed
33.
Zurück zum Zitat Mannello F, Tonti GA, Pederzoli A, Simone P, Smaniotto A, Medda V (2010) Detection of superoxide dismutase-1 in nipple aspirate fluids: a reactive oxygen species-regulating enzyme in the breast cancer microenvironment. Clin Breast Cancer 10:238–245CrossRefPubMed Mannello F, Tonti GA, Pederzoli A, Simone P, Smaniotto A, Medda V (2010) Detection of superoxide dismutase-1 in nipple aspirate fluids: a reactive oxygen species-regulating enzyme in the breast cancer microenvironment. Clin Breast Cancer 10:238–245CrossRefPubMed
34.
Zurück zum Zitat Gann PH, Geiger AS, Helenowski IB, Vonesh EF, Chatterton RT (2006) Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiol Biomarkers Prev 15:39–44CrossRefPubMed Gann PH, Geiger AS, Helenowski IB, Vonesh EF, Chatterton RT (2006) Estrogen and progesterone levels in nipple aspirate fluid of healthy premenopausal women: relationship to steroid precursors and response proteins. Cancer Epidemiol Biomarkers Prev 15:39–44CrossRefPubMed
35.
Zurück zum Zitat Noble J, Dua RS, Locke I, Eeles R, Gui GP, Isacke CM (2007) Proteomic analysis of nipple aspirate fluid throughout the menstrual cycle in healthy pre-menopausal women. Breast Cancer Res Treat 104:191–196CrossRefPubMed Noble J, Dua RS, Locke I, Eeles R, Gui GP, Isacke CM (2007) Proteomic analysis of nipple aspirate fluid throughout the menstrual cycle in healthy pre-menopausal women. Breast Cancer Res Treat 104:191–196CrossRefPubMed
36.
Zurück zum Zitat Gann P, Chatterton R, Vogelsong K, Dupuis J, Ellman A (1997) Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability. Cancer Epidemiol Biomarkers Prev 6:421–428PubMed Gann P, Chatterton R, Vogelsong K, Dupuis J, Ellman A (1997) Mitogenic growth factors in breast fluid obtained from healthy women: evaluation of biological and extraneous sources of variability. Cancer Epidemiol Biomarkers Prev 6:421–428PubMed
37.
Zurück zum Zitat Harding C, Osundeko O, Tetlow L, Faragher EB, Howell A, Bundred NJ (2000) Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity. Br J Cancer 82:354–360CrossRefPubMedPubMedCentral Harding C, Osundeko O, Tetlow L, Faragher EB, Howell A, Bundred NJ (2000) Hormonally-regulated proteins in breast secretions are markers of target organ sensitivity. Br J Cancer 82:354–360CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Chatterton RT Jr, Khan SA, Heinz R, Ivancic D, Lee O (2010) Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations. Cancer Epidemiol Biomarkers Prev 19:275–279CrossRefPubMed Chatterton RT Jr, Khan SA, Heinz R, Ivancic D, Lee O (2010) Patterns of sex steroid hormones in nipple aspirate fluid during the menstrual cycle and after menopause in relation to serum concentrations. Cancer Epidemiol Biomarkers Prev 19:275–279CrossRefPubMed
39.
Zurück zum Zitat Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG (2007) Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem 79:7813–7821CrossRefPubMed Xu X, Roman JM, Issaq HJ, Keefer LK, Veenstra TD, Ziegler RG (2007) Quantitative measurement of endogenous estrogens and estrogen metabolites in human serum by liquid chromatography-tandem mass spectrometry. Anal Chem 79:7813–7821CrossRefPubMed
40.
Zurück zum Zitat Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47CrossRefPubMed Lee MM, Lin SS, Wrensch MR, Adler SR, Eisenberg D (2000) Alternative therapies used by women with breast cancer in four ethnic populations. J Natl Cancer Inst 92:42–47CrossRefPubMed
41.
Zurück zum Zitat Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H, Diamandis E (1996) Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 5:967–970PubMed Sauter ER, Daly M, Linahan K, Ehya H, Engstrom PF, Bonney G, Ross EA, Yu H, Diamandis E (1996) Prostate-specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prev 5:967–970PubMed
42.
Zurück zum Zitat Sauter ER, Klein G, Wagner-Mann C, Diamandis EP (2004) Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer. Cancer Detect Prev 28:27–31CrossRefPubMed Sauter ER, Klein G, Wagner-Mann C, Diamandis EP (2004) Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer. Cancer Detect Prev 28:27–31CrossRefPubMed
43.
Zurück zum Zitat Sauter ER, Tichansky DS, Chervoneva I, Diamandis EP (2002) Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer. Environ Health Perspect 110:241–246CrossRefPubMedPubMedCentral Sauter ER, Tichansky DS, Chervoneva I, Diamandis EP (2002) Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer. Environ Health Perspect 110:241–246CrossRefPubMedPubMedCentral
44.
Zurück zum Zitat Qin W, Gui G, Zhang K, Twelves D, Kliethermes B, Sauter ER (2012) Proteins and carbohydrates in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy. BMC Cancer 12:52CrossRefPubMedPubMedCentral Qin W, Gui G, Zhang K, Twelves D, Kliethermes B, Sauter ER (2012) Proteins and carbohydrates in nipple aspirate fluid predict the presence of atypia and cancer in women requiring diagnostic breast biopsy. BMC Cancer 12:52CrossRefPubMedPubMedCentral
45.
Zurück zum Zitat Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD (1995) Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 52:459–467CrossRefPubMed Birrell SN, Bentel JM, Hickey TE, Ricciardelli C, Weger MA, Horsfall DJ, Tilley WD (1995) Androgens induce divergent proliferative responses in human breast cancer cell lines. J Steroid Biochem Mol Biol 52:459–467CrossRefPubMed
46.
Zurück zum Zitat Hall RE, Birrell SN, Tilley WD, Sutherland RL (1994) MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. Eur J Cancer 30A:484–490CrossRefPubMed Hall RE, Birrell SN, Tilley WD, Sutherland RL (1994) MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. Eur J Cancer 30A:484–490CrossRefPubMed
47.
Zurück zum Zitat Saito H, Kasayama S, Kouhara H, Matsumoto K, Sato B (1991) Up-regulation of fibroblast growth factor (FGF) receptor mRNA levels by basic FGF or testosterone in androgen-sensitive mouse mammary tumor cells. Biochem Biophys Res Commun 174:136–141CrossRefPubMed Saito H, Kasayama S, Kouhara H, Matsumoto K, Sato B (1991) Up-regulation of fibroblast growth factor (FGF) receptor mRNA levels by basic FGF or testosterone in androgen-sensitive mouse mammary tumor cells. Biochem Biophys Res Commun 174:136–141CrossRefPubMed
48.
Zurück zum Zitat Mohanty AK, Singh G, Paramasivam M, Saravanan K, Jabeen T, Sharma S, Yadav S, Kaur P, Kumar P, Srinivasan A, Singh TP (2003) Crystal structure of a novel regulatory 40-kDa mammary gland protein (MGP-40) secreted during involution. J Biol Chem 278:14451–14460CrossRefPubMed Mohanty AK, Singh G, Paramasivam M, Saravanan K, Jabeen T, Sharma S, Yadav S, Kaur P, Kumar P, Srinivasan A, Singh TP (2003) Crystal structure of a novel regulatory 40-kDa mammary gland protein (MGP-40) secreted during involution. J Biol Chem 278:14451–14460CrossRefPubMed
49.
Zurück zum Zitat Jensen BV, Johansen JS, Price PA (2003) High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin Cancer Res 9:4423–4434PubMed Jensen BV, Johansen JS, Price PA (2003) High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. Clin Cancer Res 9:4423–4434PubMed
50.
Zurück zum Zitat Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brunner N, Harris AL (2003) High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 80:15–21CrossRefPubMed Johansen JS, Christensen IJ, Riisbro R, Greenall M, Han C, Price PA, Smith K, Brunner N, Harris AL (2003) High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival. Breast Cancer Res Treat 80:15–21CrossRefPubMed
Metadaten
Titel
Protein Biomarkers for Breast Cancer Risk Are Specifically Correlated with Local Steroid Hormones in Nipple Aspirate Fluid
Publikationsdatum
19.04.2016
Erschienen in
Discover Oncology / Ausgabe 4/2016
Print ISSN: 1868-8497
Elektronische ISSN: 2730-6011
DOI
https://doi.org/10.1007/s12672-016-0264-3

Weitere Artikel der Ausgabe 4/2016

Discover Oncology 4/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.